Abstract
Tissues with high metabolic rates often use lipids, as well as glucose, for energy, conferring a survival advantage during feast and famine1. Current dogma suggests that high-energy–consuming photoreceptors depend on glucose2,3. Here we show that the retina also uses fatty acid β-oxidation for energy. Moreover, we identify a lipid sensor, free fatty acid receptor 1 (Ffar1), that curbs glucose uptake when fatty acids are available. Very-low-density lipoprotein receptor (Vldlr), which is present in photoreceptors4 and is expressed in other tissues with a high metabolic rate, facilitates the uptake of triglyceride-derived fatty acid5,6. In the retinas of Vldlr−/− mice with low fatty acid uptake6 but high circulating lipid levels, we found that Ffar1 suppresses expression of the glucose transporter Glut1. Impaired glucose entry into photoreceptors results in a dual (lipid and glucose) fuel shortage and a reduction in the levels of the Krebs cycle intermediate α-ketoglutarate (α-KG). Low α-KG levels promotes stabilization of hypoxia-induced factor 1a (Hif1a) and secretion of vascular endothelial growth factor A (Vegfa) by starved Vldlr−/− photoreceptors, leading to neovascularization. The aberrant vessels in the Vldlr−/− retinas, which invade normally avascular photoreceptors, are reminiscent of the vascular defects in retinal angiomatous proliferation, a subset of neovascular age-related macular degeneration (AMD)7, which is associated with high vitreous VEGFA levels in humans. Dysregulated lipid and glucose photoreceptor energy metabolism may therefore be a driving force in macular telangiectasia, neovascular AMD and other retinal diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
Change history
24 March 2016
In the version of this article initially published online, there were two errors. There was a typographical error in the text, which should have stated that the 'dark current' is an electrochemical gradient required for photon-induced polarization (rather than depolarization, as incorrectly stated). In addition, some funding sources were inadvertently omitted from the Acknowledgments. The errors have been corrected for the print, PDF and HTML versions of this article.
07 June 2016
Nat. Med.; doi: 10.1038/nm.4059; corrected 24 March 2016 In the version of this article initially published online, there were two errors. There was a typographical error in the text, which should have stated that the 'dark current' is an electrochemical gradient required for photon-induced polarization (rather than depolarization, as incorrectly stated).
References
Cahill, G.F. Jr. Starvation in man. N. Engl. J. Med. 282, 668–675 (1970).
Wong-Riley, M.T.T. Energy metabolism of the visual system. Eye Brain 2, 99–116 (2010).
Cohen, L.H. & Noell, W.K. Glucose catabolism of rabbit retina before and after development of visual function. J. Neurochem. 5, 253–276 (1960).
Dorrell, M.I. et al. Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress. J. Clin. Invest. 119, 611–623 (2009).
Niu, Y.-G. & Evans, R.D. Very-low-density lipoprotein: complex particles in cardiac energy metabolism. J. Lipids 2011, 189876 (2011).
Goudriaan, J.R. et al. The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J. Lipid Res. 45, 1475–1481 (2004).
Bottoni, F. et al. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch. Ophthalmol. 123, 1644–1650 (2005).
Yannuzzi, L.A. et al. Idiopathic macular telangiectasia. 2006. Retina 32 (suppl. 1), 450–460 (2012).
Lim, L.S., Mitchell, P., Seddon, J.M., Holz, F.G. & Wong, T.Y. Age-related macular degeneration. Lancet 379, 1728–1738 (2012).
Okawa, H., Sampath, A.P., Laughlin, S.B. & Fain, G.L. ATP consumption by mammalian rod photoreceptors in darkness and in light. Curr. Biol. 18, 1917–1921 (2008).
Mantych, G.J., Hageman, G.S. & Devaskar, S.U. Characterization of glucose transporter isoforms in the adult and developing human eye. Endocrinology 133, 600–607 (1993).
Gospe, S.M. III, Baker, S.A. & Arshavsky, V.Y. Facilitative glucose transporter Glut1 is actively excluded from rod outer segments. J. Cell Sci. 123, 3639–3644 (2010).
Klepper, J. Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet. Epilepsia 49 (suppl. 8), 46–49 (2008).
Lopaschuk, G.D., Ussher, J.R., Folmes, C.D.L., Jaswal, J.S. & Stanley, W.C. Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90, 207–258 (2010).
Obunike, J.C. et al. Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very-low-density lipoprotein receptor. J. Biol. Chem. 276, 8934–8941 (2001).
Tyni, T., Paetau, A., Strauss, A.W., Middleton, B. & Kivelä, T. Mitochondrial fatty acid β-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl–CoA dehydrogenase deficiency. Pediatr. Res. 56, 744–750 (2004).
Sarac, O., Gulsuner, S., Yildiz-Tasci, Y., Ozcelik, T. & Kansu, T. Neuro-ophthalmologic findings in humans with quadrupedal locomotion. Ophthalmic Genet. 33, 249–252 (2012).
Trick, G.L. & Berkowitz, B.A. Retinal oxygenation response and retinopathy. Prog. Retin. Eye Res. 24, 259–274 (2005).
Furukawa, T., Morrow, E.M. & Cepko, C.L. Crx, a novel Otx-like homeobox gene, shows photoreceptor-specific expression and regulates photoreceptor differentiation. Cell 91, 531–541 (1997).
Winkler, B.S. Glycolytic and oxidative metabolism in relation to retinal function. J. Gen. Physiol. 77, 667–692 (1981).
Hu, W. et al. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout-mouse model's retinal angiomatous proliferation. Invest. Ophthalmol. Vis. Sci. 49, 407–415 (2008).
Lefebvre, P., Chinetti, G., Fruchart, J.-C. & Staels, B. Sorting out the roles of PPAR-α in energy metabolism and vascular homeostasis. J. Clin. Invest. 116, 571–580 (2006).
Nakamura, M.T., Yudell, B.E. & Loor, J.J. Regulation of energy metabolism by long-chain fatty acids. Prog. Lipid Res. 53, 124–144 (2014).
Itoh, Y. et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422, 173–176 (2003).
Kebede, M. et al. The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding. Diabetes 57, 2432–2437 (2008).
Alquier, T. et al. Deletion of Gpr40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in islets. Diabetes 58, 2607–2615 (2009).
Steneberg, P., Rubins, N., Bartoov-Shifman, R., Walker, M.D. & Edlund, H. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis and impaired glucose homeostasis in mouse. Cell Metab. 1, 245–258 (2005).
Honoré, J.-C. et al. Fatty acid receptor Gpr40 mediates neuromicrovascular degeneration induced by transarachidonic acids in rodents. Arterioscler. Thromb. Vasc. Biol. 33, 954–961 (2013).
Briscoe, C.P. et al. The orphan G protein–coupled receptor GPR40 is activated by medium- and long-chain fatty acids. J. Biol. Chem. 278, 11303–11311 (2003).
Naik, H. et al. Safety, tolerability, pharmacokinetics and pharmacodynamic properties of the GPR40 agonist TAK-875: results from a double-blind, placebo-controlled single-oral-dose rising study in healthy volunteers. J. Clin. Pharmacol. 52, 1007–1016 (2012).
Kaelin, W.G. Jr. Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate–dependent dioxygenases. Cold Spring Harb. Symp. Quant. Biol. 76, 335–345 (2011).
Ohno-Matsui, K. et al. Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am. J. Pathol. 160, 711–719 (2002).
Zhou, X., Wong, L.L., Karakoti, A.S., Seal, S. & McGinnis, J.F. Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr-knockout mouse. PLoS One 6, e16733 (2011).
Chen, Y. et al. Photoreceptor degeneration and retinal inflammation induced by very-low-density lipoprotein receptor deficiency. Microvasc. Res. 78, 119–127 (2009).
Fletcher, A.L., Pennesi, M.E., Harding, C.O., Weleber, R.G. & Gillingham, M.B. Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies. Mol. Genet. Metab. 106, 18–24 (2012).
Keech, A.C. et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomized controlled trial. Lancet 370, 1687–1697 (2007).
Ferrannini, E., Barrett, E.J., Bevilacqua, S. & DeFronzo, R.A. Effect of fatty acids on glucose production and utilization in man. J. Clin. Invest. 72, 1737–1747 (1983).
Wauson, E.M., Lorente-Rodríguez, A. & Cobb, M.H. Minireview: nutrient sensing by G protein–coupled receptors. Mol. Endocrinol. 27, 1188–1197 (2013).
Warburg, O. On the origin of cancer cells. Science 123, 309–314 (1956).
Zhao, S. et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1α. Science 324, 261–265 (2009).
Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals 8th edn. (The National Academies Press, Washington, D.C., 2011).
Stahl, A. et al. Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy. Am. J. Pathol. 177, 2715–2723 (2010).
Stahl, A. et al. Computer-aided quantification of retinal neovascularization. Angiogenesis 12, 297–301 (2009).
Deerinck, T.J. et al. Enhancing serial block-face scanning electron microscopy to enable high-resolution 3D nanohistology of cells and tissues. Microsc. Microanal. 16, 1138–1139 (2010).
Spahis, S. et al. Plasma fatty acid composition in French-Canadian children with non-alcoholic fatty liver disease: effect of n-3 PUFA supplementation. Prostaglandins Leukot. Essent. Fatty Acids 99, 25–34 (2015).
Calvano, S.E. et al. A network-based analysis of systemic inflammation in humans. Nature 437, 1032–1037 (2005).
Jain, M. et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336, 1040–1044 (2012).
Townsend, M.K. et al. Reproducibility of metabolomic profiles among men and women in two large cohort studies. Clin. Chem. 59, 1657–1667 (2013).
al-Ubaidi, M.R. et al. Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter. J. Cell Biol. 119, 1681–1687 (1992).
Tan, E. et al. Expression of cone-photoreceptor–specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest. Ophthalmol. Vis. Sci. 45, 764–768 (2004).
Park, Y.K. et al. AsiDesigner: exon-based siRNA design server considering alternative splicing. Nucleic Acids Res. 36, W97–103 (2008).
Grieger, J.C., Choi, V.W. & Samulski, R.J. Production and characterization of adeno-associated viral vectors. Nat. Protoc. 1, 1412–1428 (2006).
Khani, S.C. et al. AAV-mediated expression targeting of rod and cone photoreceptors with a human rhodopsin kinase promoter. Invest. Ophthalmol. Vis. Sci. 48, 3954–3961 (2007).
Vandenberghe, L.H. et al. Efficient serotype-dependent release of functional vector into the culture medium during adeno-associated virus manufacturing. Hum. Gene Ther. 21, 1251–1257 (2010).
Acknowledgements
This work was supported by the US National Institutes of Health (NIH) grants EY024864 (L.E.H.S.), EY017017 (L.E.H.S.), EY022275 (L.E.H.S.), P01 HD18655 (L.E.H.S.) and EY024963 (J.C.) and EY11254 (Friedlander), the Lowy Medical Research Institute (M. Friedlander, L.E.H.S. and M. Fruttiger), the European Commission FP7 project 305485 PREVENT-ROP (L.E.H.S.), a Burroughs Wellcome Fund Career Award for Medical Scientists (J.-S.J.), the Foundation Fighting Blindness (J.-S.J.), the Canadian Institute of Health Research (CIHR) grant 143077 (J.-S.J.), the Fonds de Recherche du Québec–Santé (FRQS) (J.-S.J.), the Canadian Child Health Clinician Scientist Program (J.-S.J.), a CIHR New Investigator Award (J.-S.J.), the Knights Templar Eye Foundation (Z.F.), the Bernadotte Foundation (Z.F.), the Canada Research chair and CIHR grant 221478 (P.S.), the Boston Children's Hospital Ophthalmology Foundation (J.C.), a Boston Children's Hospital Faculty Career Development Award (J.C.), the Bright Focus Foundation (J.C.) and the Massachussetts Lions Eye Research Fund, Inc. (J.C.). We thank M. Puder and P. Nandivada (Harvard Medical School, Boston Children's Hospital) for sharing the Ffar1−/− mice; M. Al-Ubaidi (University of Oklahoma) for sharing the 661W photoreceptor cells; Z. Lin and W.T. Pu (Harvard Medical School, Boston Children's Hospital) for sharing a modified CAG-GFP-miR30 construct; and C. Cepko (Harvard Medical School) and T. Li (National Eye Institute) for providing the pAAV-RK-GFP vector.
Author information
Authors and Affiliations
Contributions
J.-S.J. and L.E.H.S. conceived and designed all experiments, and wrote the manuscript; and J.-S.J., Y.S., Z.S., L.P.E., N.S., T.F., S.B., J.S.K., G.P., A.M.J., C.G.H., C.J.H., Z.C. and Z.F. performed all in vivo and ex vivo experiments, except for those indicated below. M.L.G., E.A. and M. Friedlander performed and analyzed the Seahorse experiments; K.A.P. and C.B.C. performed and analyzed the metabolite profiling; P.B. and B.M. performed and analyzed fatty acid β-oxidation; M.B.P., K.V. and M. Fruttiger performed and analyzed 3D SEM; M.B. and E.L. analyzed lipid composition of plasma; F.A.R. collected human vitreous samples; P.S. measured human vitreous VEGF levels; C.B.C., M. Friedlander, J.C., P.S., B.M., F.A.R., A.P., M. Fruttiger and E.L. provided expert advice. All of the authors analyzed the data.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–10 and Supplementary Tables 1–2 (PDF 10547 kb)
WT photoreceptor mitochondria.
Video of pseudo-colored mitochondria in WT photoreceptors by 3D reconstruction of scanning electron microscopy (MOV 4894 kb)
Vldlr−/− photoreceptor mitochondria.
Video of pseudo-colored mitochondria in Vldlr−/− photoreceptors by 3D reconstruction of scanning electron microscopy. A vascular lesion (center) is pseudocoloured in green. (MOV 15200 kb)
Ffar1 dictates glucose uptake in Vldlr−/− retina.
[18F]FDG microPET / CT scan comparing glucose uptake simultaneously in WT (left), Vldlr−/− (middle left), Vldlr−/− /Ffar1−/− (middle right) and Ffar1−/− mice (right) (MPG 982 kb)
Rights and permissions
About this article
Cite this article
Joyal, JS., Sun, Y., Gantner, M. et al. Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1. Nat Med 22, 439–445 (2016). https://doi.org/10.1038/nm.4059
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4059
This article is cited by
-
Photoreceptors inhibit pathological retinal angiogenesis through transcriptional regulation of Adam17 via c-Fos
Angiogenesis (2024)
-
Deficits in mitochondrial TCA cycle and OXPHOS precede rod photoreceptor degeneration during chronic HIF activation
Molecular Neurodegeneration (2023)
-
Fructose promotes angiogenesis by improving vascular endothelial cell function and upregulating VEGF expression in cancer cells
Journal of Experimental & Clinical Cancer Research (2023)
-
Mathematical model for glutathione dynamics in the retina
Scientific Reports (2023)
-
FGF21 via mitochondrial lipid oxidation promotes physiological vascularization in a mouse model of Phase I ROP
Angiogenesis (2023)